These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 1694156

  • 41. [Cured from Hodgkin's disease].
    Brice P.
    Bull Cancer; 2002; 89(7-8):666-70. PubMed ID: 12206979
    [Abstract] [Full Text] [Related]

  • 42. Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
    Dhabhar BN, Malhotra H, Joseph R, Garde S, Bhasin S, Sheth A, Advani SH.
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):306-10. PubMed ID: 8328644
    [Abstract] [Full Text] [Related]

  • 43. [Efficacy of lomustine, teniposide, doxorubicin, bleomycin and prednisone (LTABP) or adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) in the treatment of malignant lymphogranulomatosis resistant to MOPP].
    Robak T, Krykowski E, Płuzańska A, Olszańska-Skorek T, Kowalczyński M, Urbańska-Ryś H.
    Pol Tyg Lek; 1993 Aug; 45(21-22):426-9. PubMed ID: 1702536
    [Abstract] [Full Text] [Related]

  • 44. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG, Levis A, Chisesi T, Broglia C, Vitolo U, Stelitano C, Pavone V, Cavanna L, Santini G, Merli F, Liberati M, Baldini L, Deliliers GL, Angelucci E, Bordonaro R, Federico M, Intergruppo Italiano Linfomi.
    J Clin Oncol; 2005 Dec 20; 23(36):9198-207. PubMed ID: 16172458
    [Abstract] [Full Text] [Related]

  • 45. Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology Group.
    Takenaka T, Mikuni C, Miura A, Sasaki T, Suzuki H, Hotta T, Hirano M, Fukuhara S, Sugiyama H, Nasu K, Dohi H, Kozuru M, Tomonaga M, Tajima K, Niimi M, Fukuda H, Mukai K, Shimoyama M.
    Jpn J Clin Oncol; 2000 Mar 20; 30(3):146-52. PubMed ID: 10798542
    [Abstract] [Full Text] [Related]

  • 46. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
    Harker WG, Kushlan P, Rosenberg SA.
    Ann Intern Med; 1984 Oct 20; 101(4):440-6. PubMed ID: 6206757
    [Abstract] [Full Text] [Related]

  • 47. ABVD in the treatment of Hodgkin's disease.
    Bonfante V, Santoro A, Viviani S, Valagussa P, Bonadonna G.
    Semin Oncol; 1992 Apr 20; 19(2 Suppl 5):38-44; discussion 44-5. PubMed ID: 1384143
    [Abstract] [Full Text] [Related]

  • 48. Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
    Bujan L, Walschaerts M, Brugnon F, Daudin M, Berthaut I, Auger J, Saias J, Szerman E, Moinard N, Rives N, Hennebicq S.
    Fertil Steril; 2014 Sep 20; 102(3):667-674.e3. PubMed ID: 25044088
    [Abstract] [Full Text] [Related]

  • 49. Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens.
    Bonadonna G, Santoro A, Viviani S, Lombardi C, Ragni G.
    Arch Toxicol Suppl; 1984 Sep 20; 7():140-5. PubMed ID: 6083763
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Cancer of the testis after Hodgkin's disease. Apropos of 2 cases].
    Robert M, Averous M, Lavabre-Bertrand T, Iborra F, Chevallier P, Rebillard X, Guiter J, Grasset D.
    J Urol (Paris); 1992 Sep 20; 98(3):178-80. PubMed ID: 1282922
    [Abstract] [Full Text] [Related]

  • 52. [Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993].
    Naccache P, Decaudin D, Koscielny S, Bendahmane B, Auger J, Munck JN.
    Bull Cancer; 1996 Apr 20; 83(4):307-14. PubMed ID: 8680082
    [Abstract] [Full Text] [Related]

  • 53. Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
    Santoro A, Bonadonna G.
    Cancer Chemother Pharmacol; 1979 Apr 20; 2(2):101-5. PubMed ID: 93984
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.
    Amin MSA, Brunckhorst O, Scott C, Wrench D, Gleeson M, Kazmi M, Ahmed K.
    Clin Transl Oncol; 2021 Jun 20; 23(6):1067-1077. PubMed ID: 32944834
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Fertility in young patients following treatment for Hodgkin's lymphoma: a single center survey.
    Boltežar L, Pintarić K, Jezeršek Novaković B.
    J Assist Reprod Genet; 2016 Mar 20; 33(3):325-333. PubMed ID: 26678493
    [Abstract] [Full Text] [Related]

  • 59. Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
    da Cunha MF, Meistrich ML, Fuller LM, Cundiff JH, Hagemeister FB, Velasquez WS, McLaughlin P, Riggs SA, Cabanillas FF, Salvador PG.
    J Clin Oncol; 1984 Jun 20; 2(6):571-7. PubMed ID: 6547167
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.